Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile
Invasive meningococcal disease (IMD) is an uncommon yet unpredictable, severe, and life-threatening disease with the highest burden in young children. In Chile, most IMD is caused by meningococcal serogroup B (MenB) and W (MenW) infection. In response to a MenW outbreak in 2012, a toddler vaccinatio...
Main Authors: | María Gabriela Graña, Gabriel Cavada, Marjorie Vasquez, Jing Shen, Johan Maervoet, Johan Klint, Jorge A. Gómez |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-12-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2021.1996808 |
Similar Items
-
Real-world impact and effectiveness of MenACWY-TT
by: Rodolfo Villena, et al.
Published: (2023-08-01) -
Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age
by: Gary S. Marshall, et al.
Published: (2022-11-01) -
Assessing the Role of Infant and Toddler MenACWY Immunisation in the UK: Does the Adolescent MenACWY Programme Provide Sufficient Protection?
by: Katharina Schley, et al.
Published: (2023-05-01) -
Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccines
by: Lidia Serra, et al.
Published: (2021-07-01) -
Psychosocial and organizational barriers and facilitators of meningococcal vaccination (MenACWY) acceptance among adolescents and parents during the Covid-19 pandemic: a cross-sectional survey
by: Veja Widdershoven, et al.
Published: (2022-05-01)